Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

NCT03910387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Unresectable Pancreatic Adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
Recurrent Pancreatic Adenocarcinoma
Stage III Pancreatic Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8

Interventions

DRUG: Gemcitabine
DRUG: Nab-paclitaxel
DRUG: Telotristat Ethyl

Sponsor

Emory University

Collaborators

[object Object]
[object Object]